Akari Therapeutics, Plc AKTX · Insights

website

Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-kil...

Price7.66

Market Cap17.82 M

Float1.94 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Key Dates & Timelines

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro

Financial Transactions

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro